Jenny Wei
About Jenny Wei
Jenny Wei serves as the Senior Director and Head of R&D Information at Kite Pharma, where she has worked since 2021. She holds a Master's degree in Computer Science from Rutgers University and has extensive experience in informatics and R&D across several leading pharmaceutical companies.
Current Role at Kite Pharma
Jenny Wei serves as the Senior Director and Head of R&D Information at Kite Pharma, a position she has held since 2021. In this role, she leads initiatives focused on research and development information management. Her responsibilities include executing the Kite2.0 strategy, which aims to innovate next-generation CAR designs and facilitate data-driven predictions for product lifecycle management. Wei's efforts have contributed to significant advancements in the development of cell therapies.
Previous Experience in Pharmaceutical Industry
Prior to her current role, Jenny Wei accumulated extensive experience in the pharmaceutical sector. She worked at Merck as a Principal Informatics Developer from 2002 to 2008. Wei also held several positions at AstraZeneca, including Head of Discovery Information and Director of R&D Information for Asia & Emerging Markets. Additionally, she served as Director at Juno Therapeutics, Inc. and Bristol Myers Squibb, focusing on R&D informatics and digital innovation.
Educational Background
Jenny Wei holds a Master’s degree in Computer Science from Rutgers University and a Bachelor of Science in Biochemical Engineering from Shanghai Jiao Tong University. She also earned a Ph.D. in Pharmacology from the University of Washington. Furthermore, Wei completed the Stanford Executive Program at Stanford University Graduate School of Business, enhancing her leadership and strategic skills.
Achievements in Cell Therapy Development
Jenny Wei has made notable contributions to the field of cell therapy. She streamlined the development of autologous and allogeneic cell therapy products and optimized clinical manufacturing processes using Health Cloud CGT and clinical control tower technologies. Wei established GCP/GVP/GCLP capabilities to support regulatory submissions and inspections, advancing cell therapy applications for second-line LBCL. Her initiatives have also led to a 30% reduction in clinical data review cycle times.
Innovations in Research Ecosystems
Throughout her career, Jenny Wei has focused on building innovative research ecosystems. She developed a multi-modal research ecosystem for solid tumor targeting and CAR structure/activity modeling. Wei automated data pipelines using SaaS tools and AWS Omics, which enhanced data management capabilities within R&D. Her work has been instrumental in advancing the efficiency and effectiveness of research initiatives in the pharmaceutical industry.